Friday, October 21, 2016

Alphosyl '2 in 1' Shampoo





1. Name Of The Medicinal Product



Alphosyl '2 in 1' Shampoo


2. Qualitative And Quantitative Composition



Alcoholic extract of coal tar 5.00% w/w



For excipients see 6.1



3. Pharmaceutical Form



Medicated Shampoo



4. Clinical Particulars



4.1 Therapeutic Indications



For the treatment of Psoriasis, Seborrhoeic dermatitis, scaling and itching (often associated with eczema), and dandruff



4.2 Posology And Method Of Administration



Adults, children and the elderly:



Wet hair thoroughly, then briskly rub a liberal amount of shampoo into the hair and scalp. Rinse thoroughly and repeat the procedure massaging the scalp for several minutes and working the shampoo into a rich lather. Rinse thoroughly.



Dandruff: Once or twice weekly as necessary or as directed by a physician.



Psoriasis, Seborrhoeic dermatitis, scaling and itching: Use every 2 or 3 days or as directed by a physician.



4.3 Contraindications



Sensitivity to coal tar or to any of the excipients



4.4 Special Warnings And Precautions For Use



For external use only



Discontinue if irritation develops



Avoid contact with eyes



Keep out of reach of children



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None known



4.6 Pregnancy And Lactation



There is no or inadequate evidence of safety of coal tar in human pregnancy but it has been in wide use for many years without apparent ill consequence. However, use in the first trimester of pregnancy is best avoided.



4.7 Effects On Ability To Drive And Use Machines



None known



4.8 Undesirable Effects



Adverse events are tabulated below by system class. The frequency of these adverse events is not known, but post marketing experience indicates that adverse reactions are rare or very rare.










Body System




Undesirable effect




Skin and subcutaneous tissue disorders




Skin irritation



Photosensitivity




Immune system disorders




Hypersensitivity (including rash, itching, dyspnoea and angioedema)



These undesirable effects resolve when treatment is stopped.



4.9 Overdose



Alphosyl shampoo is a topical medicine which has no known systemic effects. Effects of overdose may increase the rate of skin irritation and photosensitivity but it is unlikely to have a systemic effect.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Coal tar has keratolytic and keratoplastic properties which aids treatment by slowing the excessive epidermal cell turnover.



5.2 Pharmacokinetic Properties



Not applicable



5.3 Preclinical Safety Data



Not applicable



6. Pharmaceutical Particulars



6.1 List Of Excipients



Sodium lauryl sulphate solution



Ammonium lauryl sulphate solution



Lauramide DEA



Herbal Fragrance 41.423



Hydroxy Propyl Methyl Cellulose



Citric acid anhydrous



Guar Hydroxy Propyl Trimonium Chloride



Methyl Parahydroxybenzoate



Propyl Parahydroxybenzoate



Patent Blue V dye



Purified Water



6.2 Incompatibilities



None known



6.3 Shelf Life



24 months



6.4 Special Precautions For Storage



None



6.5 Nature And Contents Of Container



Alphosyl '2 in 1' shampoo is packaged in white opaque polypropylene bottles with wadded cap and pack sizes; 20, 100, 125, 250, 500 and 1000 ml



or



White opaque polypropylene bottles with a white polypropylene flip top cap and pack sizes 125 and 250ml.



It is also packaged in white opaque polypropylene tubes with screw cap and pack sizes 20, 100, 125, 250, 500 and 1000 ml.



It is also packaged in 10 ml PETP/PE/Foil Surlyn sachets.



6.6 Special Precautions For Disposal And Other Handling



None stated



7. Marketing Authorisation Holder



Stafford-Miller Limited



980 Great West Road



Brentford



Middlesex



TW8 9GS



Trading as: GlaxoSmithKline Consumer Healthcare, Brentford TW8 9GS, UK



8. Marketing Authorisation Number(S)



PL 00036/0052



9. Date Of First Authorisation/Renewal Of The Authorisation



13/11/1991 / 28/05/2003



10. Date Of Revision Of The Text



24/11/2010




No comments:

Post a Comment